Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer
Status: Enrolling, Phase I
Updated: 1/14/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Hospital of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Central Nervous System Neoplasms Clinical Trial
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
Status: Enrolling
Updated: 1/19/2016
UNMC/Nebraska Medicine
mi
from
Omaha, NE
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Status: Enrolling
Updated: 2/20/2015
Hypertension Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Status: Enrolling
Updated: 2/20/2015
Research Physicians Network Alliance
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Urologic Consultants, PC
mi
from
Wyoming, MI
Click here to add this to my saved trials
Induction of Labor Clinical Trial
Foley Labor Induction Trial at Term and in PROM
Status: Enrolling
Updated: 5/18/2016
Elmhurst Hospital Center
mi
from
Elmhurst, NY
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Sickle Cell Clinical Research and Intervention Program
Status: Enrolling, Phase
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Acute Cholecystitis Clinical Trial
Functional MRC With Eovist for Acute Cholecystitis
Status: Enrolling
Updated: 12/1/2015
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Carcinoma, Squamous Cell of Head and Neck Clinical Trial
PD 0332991 and Cetuximab in Patients With Incurable SCCHN
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Carcinoma, Squamous Cell of Head and Neck Clinical Trial
PD 0332991 and Cetuximab in Patients With Incurable SCCHN
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
HIV Clinical Trial
Strength Training and Endurance Exercise for LIFE
Status: Enrolling
Updated: 12/31/1969
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Assessment of Myocardial Tissue Damage in Aortic Stenosis
Status: Enrolling
Updated: 1/4/2016
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
Status: Enrolling, Phase II
Updated: 12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
Status: Enrolling, Phase II
Updated: 12/31/1969
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
Status: Enrolling, Phase II
Updated: 12/31/1969
Indiana Unversity
mi
from
Indianapolis, IN
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Nemours Children's Clinic - Pensacola
mi
from
Pensacola, FL
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan State University Clinical Center
mi
from
East Lansing, MI
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Golisano Children's Hospital of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospitals and Clinics of Minnesota - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Laura and Isaac Perlmutter Cancer Center @ NYU Langone
mi
from
New York, NY
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital and Medical Center of Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSF Medical Center-Mission Bay
mi
from
San Francisco, CA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph's Hospital/Children's Hospital-Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Arizona Medical Center University Campus
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Status: Enrolling, Phase I
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology, Rheumatology Clinical Trial
Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hypertension Clinical Trial
Neural Mechanism of Aldosterone-induced Insulin Resistance
Status: Enrolling, Phase IV
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Anemia Clinical Trial
Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Carl R. Darnall Army Medical Center
mi
from
Fort Hood, TX
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood
Status: Enrolling, Phase I
Updated: 4/2/2014
MedStar Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Consultants Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Freeman Cancer Institute
mi
from
Joplin, MO
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Quincy Medical Group
mi
from
Quincy, IL
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Sandford Research/USD
mi
from
Sioux Falls, ND
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
SMO Sanford Research
mi
from
Sioux Falls, ND
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Research/USD
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
St Mary Regional Cancer Center
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Palm Beach Cancer Institue
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Advanced Solid Tumor Clinical Trial
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Status: Enrolling, Phase I
Updated: 1/24/2016
University of Pennsylvania--Abramson Cancer Center Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Perceval S Aortic Heart Valve Study- North America
Status: Enrolling
Updated: 11/20/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Perceval S Aortic Heart Valve Study- North America
Status: Enrolling
Updated: 11/20/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Perceval S Aortic Heart Valve Study- North America
Status: Enrolling
Updated: 11/20/2015
East Alabama Medical Center
mi
from
Opelika, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Perceval S Aortic Heart Valve Study- North America
Status: Enrolling
Updated: 11/20/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Perceval S Aortic Heart Valve Study- North America
Status: Enrolling
Updated: 11/20/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Adjuvant Chemotherapy in Patients With High Risk Stage I Non-squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2013
Highlands Oncology Group, P.A.
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Avera Cancer Institute-Aberdeen
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Bixby Medical Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital-Cedar Crest
mi
from
Allentown, PA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Langlade Hospital and Cancer Center
mi
from
Antigo, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Center of Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
MedStar Franklin Square Medical Center/Weinberg Cancer Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Flaget Memorial Hospital
mi
from
Bardstown, KY
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Boulder Community Hospital
mi
from
Boulder, CO
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Saint Joseph's Medical Center
mi
from
Brainerd, MN
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cox Cancer Center Branson
mi
from
Branson, MO
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Harrison HealthPartners Hematology and Oncology-Bremerton
mi
from
Bremerton, WA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Regional Cancer Center
mi
from
Bryan, TX
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Highline Medical Center-Main Campus
mi
from
Burien, WA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Medical Center
mi
from
Canton, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Oncology
mi
from
Casper, WY
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Dayton Physicians LLC-Miami Valley South
mi
from
Centerville, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Adena Regional Medical Center
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology Care Inc - Kenwood
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
TriHealth Cancer Institute-Westside
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Oncology and Hematology Care Southeast
mi
from
Clackamas, OR
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials